FDA MedWatch Safety Alerts
Updated: 43 weeks 6 days ago
Tue, 04/05/2011 - 12:15
Products marketed as dietary supplements contain undeclared analogue of sildenafil, a drug which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Fri, 04/01/2011 - 11:32
The deployment tube may detach during use and may result in the failure of the product to operate, This may cause serious injury and/or death.
Fri, 04/01/2011 - 10:50
Small particles (debris) may be found inside the catheter and potentially travel (embolize) from the catheter to tissues, blood vessels, limbs and organs which can result in serious injury and /or death.
Wed, 03/30/2011 - 18:43
Use of contaminated products may lead to bacterial infection of the blood.
Wed, 03/30/2011 - 12:40
Potential for product breakdown and loss of potency if not dispensed and stored in the original bottle or blister package.
Tue, 03/29/2011 - 14:25
Products marketed as dietary supplement contain drug ingredients sulfosildenafil or tadalafil, which may interact with
nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Tue, 03/29/2011 - 13:25
Use of recalled product can result in elevated blood glucose levels (hyperglycemia), which can lead to serious health complications including death.
Tue, 03/29/2011 - 11:55
Reports of consumers experiencing decreased renal function, elevated levels of calcium in the blood, fatigue, heart arrhythmia, vomiting, and diarrhea.
Mon, 03/28/2011 - 14:20
Product marketed as a dietary supplement contains sibutramine, which may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Mon, 03/28/2011 - 13:35
Non-sterility of a chemotherapeutic product administered via the intravenous route has the potential to result in infections which could be fatal, especially in patients who are immunocompromised.
Mon, 03/28/2011 - 13:15
Bottles labeled as citalopram may contain finasteride.
Thu, 03/24/2011 - 13:08
Product marketed as dietary supplement contains terazosin, adverse health consequences that could occur with the use of this product would be hypotension, dizziness, or syncope.
Wed, 03/23/2011 - 18:58
UPDATED 03/23/2011. Eli Lilly notified customers not to use Prep Pads in black starter kits for Forteo [teriparatide (rDNA origin) injection]. Use of contaminated alcohol prep pads, alcohol swabs or alcohol swabsticks could lead to life-threatening infections.
Fri, 03/18/2011 - 19:40
Use of contaminated Povidone Prep Pads could lead to life-threatening infections, especially in at risk populations, including neonates, immune suppressed patients, and surgical patients.
Fri, 03/18/2011 - 17:15
UPDATED 03/18/2011. Dexamethasone Sodium Phosphate Injection products recalled.
Thu, 03/17/2011 - 19:55
Possible false-negative results may occur. This may cause serious adverse consequences and/or death.
Wed, 03/16/2011 - 20:05
Product marketed as dietary supplement contains Sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Tue, 03/08/2011 - 15:55
New Warning about serious heart, kidney, or breathing problems which can be fatal.
Fri, 03/04/2011 - 16:35
Increased risk of oral clefts in infants born to women treated with Topamax (topiramate) during pregnancy.
Fri, 03/04/2011 - 14:50
Endotoxins in product can cause serious illness, at times fatal.